Skip to main content
. 2023 Sep 2;15(17):4395. doi: 10.3390/cancers15174395

Table 1.

This table summarizes all relevant basic demographic data of the patients included in this study. The numbers are separately listed for each MDT/SB, as well as overall.

Overall
N = 983
MDT/SB-A
N = 610
MDT/SB-B
N = 373
p-Value
Female 452 (46.0%) 283 (46.4%) 169 (45.3%) 0.74
Age at diagnosis 58.0 (1.0, 95.0) 60.0 (8.0, 93.0) 56.0 (1.0, 95.0) 0.001
Bone tumors
    Chondrogenic
    Osteogenic
    Vascular
    Others/Unknown
Soft-tissue tumors
    Adipocytic
    (Myo-)fibroblastic
    Fibrohistiocytic
    Muscle tumors
    Undifferentiated/un-
    classified
    Others

44 (4.5%)
19 (1.9%)
18 (1.8%)
81 (8.2%)

201 (20.5%)
117 (11.9%)
33 (3.4%)
82 (8.3%)
87 (8.9%)

301 (30.6%)

24 (3.9%)
6 (1.0%)
14 (2.3%)
60 (9.8%)

141 (23.1%)
59 (9.7%)
11 (1.8%)
51 (8.4%)
50 (8.2%)

194 (31.8%)

20 (5.4%)
13 (3.5%)
4 (1.1%)
21 (5.6%)

60 (16.1%)
58 (15.6%)
22 (5.9%)
31 (8.3%)
37 (9.9%)

107 (28.6%)
<0.001
Primary tumor site
    Appendicular
    Axial
    NA

558 (56.8%)
367 (37.3%)
58 (5.9%)

352 (57.7%)
220 (36.1%)
38 (6.1%)

206 (55.2%)
147 (39.4%)
20 (5.4%)
0.37
Metastasis at diagnosis 44 (4.5%) 26 (4.3%) 18 (4.8%) 0.75